Back to Search
DR. DAVID RICHARD BROWN MD
MD
Otolaryngology Physician
NPI: 1033260633IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngic Allergy Physician
Otolaryngology — Otolaryngic Allergy
Code: 207YX0602X
87-210(NM)
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
87-210(NM)
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 1982
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).
PMID 24518078·Br J Ophthalmol·2014
4-observational
Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration.
PMID 22300011·Expert Opin Pharmacother·2012
6-review
Aflibercept (eylea) for age-related macular degeneration.
PMID 22354219·Med Lett Drugs Ther·2012
6-review
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
PMID 21526923·N Engl J Med·2011
4-observational
Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
PMID 21055816·Ophthalmology·2011
8-other
Vascular endothelial growth factor Trap-Eye for diabetic macular oedema.
PMID 19174397·Br J Ophthalmol·2009
8-other
Predicted biological activity of intravitreal VEGF Trap.
PMID 18356264·Br J Ophthalmol·2008
4-observational
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
PMID 17386270·Am J Ophthalmol·2007
3-trial
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
PMID 17021319·N Engl J Med·2006
4-observational
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
PMID 16458968·Ophthalmology·2006
5-case
Cystoid macular degeneration in chronic central serous chorioretinopathy.
PMID 12652224·Retina·2003
8-other
Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
PMID 11927845·Retina·2002
3-trial
VEGF-Trap: a VEGF blocker with potent antitumor effects.
PMID 12177445·Proc Natl Acad Sci U S A·2002
7-preclinical
Relationship between micellar and hemi-micellar processes and the bioavailability of surfactant-solubilized hydrophobic organic compounds.
PMID 17593718·Environ Sci Technol·2007
8-other
Comparative assessment of coal tars obtained from 10 former manufactured gas plant sites in the eastern United States.
PMID 16698063·Chemosphere·2006
4-observational
Effects of nonionic surfactants on the cell surface hydrophobicity and apparent hamaker constant of a Sphingomonas sp.
PMID 16433351·Environ Sci Technol·2006
8-other
Collision efficiency distribution of a bacterial suspension flowing through porous media and implications for field-scale transport.
PMID 16580704·Water Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via DAVID R BROWN, MD EAR, NOSE & THROAT PC · 2 locations total
- Address
- 435 SAINT MICHAELS DR STE B104
SANTA FE, NM 87505 - Phone
- (505) 820-9945
Quick Facts
- NPI
- 1033260633
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 44
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile